Nebenwirkungen · Idacio
Idacio 40 mg solution for injection in pre-filled syringe Idacio 40 mg solution for injection in pre-filled pen · Abschnitt 4.8 · PDF-Seite 23
HOS-139637 · Präparat HOS-098376
* further information is found elsewhere in sections 4.3, 4.4 and 4.8 ** including open label extension studies 1) including spontaneous reporting data 2) The mean weight change from baseline for adalimumab ranged from 0.3 kg to 1.0 kg across adult indications compared to (minus) -0.4 kg to 0.4 kg for placebo over a treatment period of 4-6 months. Weight increase of 5-6 kg has also been observed in long-term extension studies with mean exposures of approximately 1-2 years without control group, particularly in patients with Crohn’s disease and ulcerative colitis. The mechanism behind this effect is unclear but could be associated with the anti- inflammatory effect of adalimumab.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-21T09:15:00Z · SHA-256 830b751a6257c027493b1bf575066a54242ca302ec087403c112a09c1c15e7a3 · Passage ba5ff4157fefb891f3a800d03b9609390f7928d59c2bb03684b3fe9448d5914c · Zeichen 16200–16893 im Abschnitt